Literature DB >> 3596801

Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

T J Inzana.   

Abstract

The capsular polymer (CP) of Haemophilus pleuropneumoniae serotype 5 was purified, and its chemical composition was analyzed. Radioimmunoassay experiments showed that the maximum amount of CP could be obtained from broth cultures of bacteria in the late stationary phase, rather than from bacteria washed off agar plates. The CP was precipitated from culture supernatant with 5 mM hexadecyltrimethylammonium bromide (Cetavlon) and solubilized with 0.4 M NaCl. Ninety percent of the CP in the culture supernatant was precipitated with Cetavlon, although some material remained insoluble after NaCl extraction. The CP was further purified by phenol extraction, ultracentrifugation, and Sepharose CL-4B gel filtration. The Kav of the CP from Sepharose CL-4B chromatography was 0.33. The CP preparation contained 85% hexosamine, 12% hexose, 3% phosphate, 0.17% protein, 0.20% nucleic acid, and 0.01% endotoxin. Thin-layer chromatography, an amino acid analyzer, and a glucose oxidase colorimetric kit were used to identify the sugar components of the hydrolyzed CP as glucosamine and glucose. Analysis of the native CP by 13C nuclear magnetic resonance indicated that amino, N-acetyl, and carboxyl groups were present and that the CP was a disaccharide.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596801      PMCID: PMC260560          DOI: 10.1128/iai.55.7.1573-1579.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Procedure for determining heptose and hexose in lipopolysaccharides. Modification of the cysteine-sulfuric acid method.

Authors:  B G Wright; P A Rebers
Journal:  Anal Biochem       Date:  1972-10       Impact factor: 3.365

2.  [Haemophilus infection in pigs. 3. Serological studies on Haemophilus parahaemolyticus].

Authors:  J Nicolet
Journal:  Zentralbl Bakteriol Orig       Date:  1971

3.  A simplification of the radioactive antigen-binding test by a double label technique.

Authors:  E C Gotschlich
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

4.  Serological characterization of Haemophilus pleuropneumoniae (Actinobacillus pleuropneumoniae) strains and proposal of a new serotype: serotype 10.

Authors:  R Nielsen
Journal:  Acta Vet Scand       Date:  1985       Impact factor: 1.695

5.  Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana; B Mathison
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Structural studies of the capsular polysaccharide from Haemophilus pleuropneumoniae serotype 1.

Authors:  E Altman; J R Brisson; M B Perry
Journal:  Biochem Cell Biol       Date:  1986-08       Impact factor: 3.626

7.  Resistance of C3H/HeJ mice to the effects of Haemophilus pleuropneumoniae.

Authors:  B W Fenwick; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

8.  Isolation and biological characterization of two lipopolysaccharides and a capsular-enriched polysaccharide preparation from Haemophilus pleuropneumoniae.

Authors:  B W Fenwick; B I Osburn; H J Olander
Journal:  Am J Vet Res       Date:  1986-07       Impact factor: 1.156

9.  Interaction between heat-stable hemolytic substance from Haemophilus pleuropneumoniae and porcine pulmonary macrophages in vitro.

Authors:  K Kume; T Nakai; A Sawata
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  16 in total

1.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

2.  Detection of serotype-specific antibodies or capsular antigen of Actinobacillus pleuropneumoniae by a double-label radioimmunoassay.

Authors:  T J Inzana; G F Clark; J Todd
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana; B Mathison
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Serodiagnosis of pleuropneumonia using enzyme-linked immunosorbent assay with capsular polysaccharide antigens of Actinobacillus pleuropneumoniae serotypes 1, 2, 5 and 7.

Authors:  J T Bossé; R P Johnson; S Rosendal
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

5.  Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.

Authors:  W Byrd; S Kadis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae.

Authors:  J N Ma; T J Inzana
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Immunogenicity of Actinobacillus pleuropneumoniae outer membrane proteins and enhancement of phagocytosis by antibodies to the proteins.

Authors:  R N Thwaits; S Kadis
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

8.  Oral and aerosol immunization with viable or inactivated Actinobacillus pleuropneumoniae bacteria: antibody response to capsular polysaccharides in bronchoalveolar lavage fluids (BALF) and sera of pigs.

Authors:  A Hensel; R Pabst; S Bunka; K Petzoldt
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Cloning and mutagenesis of a serotype-specific DNA region involved in encapsulation and virulence of Actinobacillus pleuropneumoniae serotype 5a: concomitant expression of serotype 5a and 1 capsular polysaccharides in recombinant A. pleuropneumoniae serotype 1.

Authors:  C K Ward; M L Lawrence; H P Veit; T J Inzana
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  Capsular polysaccharide antigens for detection of serotype-specific antibodies to Actinobacillus pleuropneumoniae.

Authors:  J T Bossé; R P Johnson; S Rosendal
Journal:  Can J Vet Res       Date:  1990-06       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.